Table 1: Demographic and clinical data of the patients at baseline.

Patients with RAPatients with PsA
MTX groupEtanercept groupMTX groupEtanercept group

Patient, (females) 7 (5) 5 (4) 5 (2) 5 (1)
Age, mean (SD)45.7 (11.7)60.0 (10)45.4 (14.1)50.2 (11)
Disease duration (months), mean (SD)1.7 (0.2)26.8 (9.5)1.8 (0.3)33 (9.5)
DAS28, mean (SD)6.6 (0.9)6.7 (0.9)5.4 (0.7) 5.3 (0.6)
BMD of the examined joint, mean (SD)0.291 (0.067)0.319 (0.028)0.340 (0.018)0.363 (0.057)

PDUS: power Doppler US. DAS values between groups were not statistically significant.